# Identification of c-Src as a Potential Therapeutic Target for Gastric Cancer and of MET Activation as a Cause of Resistance to c-Src Inhibition

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/identification-of-c-src-as-a-potential-therapeutic-target-for-gastric-cancer-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Wataru Okamoto,Isamu Okamoto,Takeshi Yoshida,Kunio Okamoto,Ken Takezawa,Erina Hatashita,Yuki Yamada,Kiyoko Kuwata,Tokuzo Arao,Kazuyoshi Yanagihara,Masahiro Fukuoka,Kazuto Nishio,Kazuhiko Nakagawa |
| Citations | 64 |
| DOI | 10.1158/1535-7163.mct-10-0002 |
| Fields | Biochemistry, Genetics and Molecular Biology,Chemistry,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2150891833 |
| PMID | 20406949 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Kunio Okamoto](https://scholariq.org/researchers/kunio-okamoto/)

## Paper primary topic

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Paper topics

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Quinazolinone synthesis and applications](https://scholariq.org/topics/quinazolinone-synthesis-and-applications/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.